Oropharyngeal Microbiota Clusters in Children with Asthma or Wheeze Associate with Allergy, Blood Transcriptomic

Mahmoud I Abdel-Aziz1,2,3,4, Jonathan Thorsen5,6, Simone Hashimoto1,7,2,3

  • 1Department of Pulmonary Medicine and.

Insights

Childhood asthma and wheezing are linked to distinct oropharyngeal microbial communities. These four clusters show varied clinical traits and link to airway remodeling pathways, offering new treatment avenues.

Area of Science:

  • Pediatric respiratory medicine
  • Microbiome research
  • Immunology

Background:

  • Airway microbial imbalances are reported in children with preschool wheezing and school-age asthma.
  • Understanding these imbalances is crucial for identifying distinct disease phenotypes.

Purpose of the Study:

  • To identify distinct clusters within children experiencing asthma or wheezing based on their oropharyngeal microbiota profiles.
  • To correlate these microbial clusters with clinical characteristics and exacerbation risk.

Main Methods:

  • 16S ribosomal RNA gene sequencing was used to characterize oropharyngeal microbiota in 241 children from the U-BIOPRED cohort.
  • Unsupervised hierarchical clustering identified four distinct taxa-driven clusters.
  • Blood transcriptome analysis assessed transcriptomic pathway enrichment.

Main Results:

  • Four oropharyngeal microbiota clusters dominated by Streptococcus, Veillonella, Rothia, and Haemophilus were identified.
  • Clusters differed significantly in atopic dermatitis, grass pollen sensitization, lung function (FEV1), and asthma exacerbation frequency.
  • The Veillonella cluster showed higher allergic burden and exacerbation rates, with elevated TGF-β signaling.

Conclusions:

  • Oropharyngeal microbiota profiling in children with asthma/wheezing reveals four distinct phenotypes associated with exacerbation risk.
  • These phenotypes correlate with specific transcriptomic pathways involved in airway remodeling.
  • Further research into the oropharyngeal microbiome may uncover novel pathophysiological insights and therapeutic strategies for pediatric asthma.

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
470
Allergic Reactions02:06

Allergic Reactions

Overview
27.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
364